- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03991026
Healthy Foods and Education to Treat Diabetes
8. november 2019 opdateret af: Johns Hopkins University
Farm to Clinic Vegetable Initiative at East Baltimore Medical Center
The investigators will study a program that delivers weekly community-supported agriculture shares to patients of East Baltimore Medical Center in order to increase access to healthy foods.
The investigators will provide adult patients with uncontrolled diabetes with healthy foods including fresh vegetables and shelf-stable pantry items (e.g., canned beans) every week over the course of 6 weeks.
The investigators will also collect demographic data and food insecurity status of participants via survey.
This program will also conduct weekly cooking and nutrition classes at East Baltimore Medical Center.
The investigators will conduct a survey of participants' experiences each time participants pick up a vegetable bag and at the end of the cooking classes.
In addition, a focus group of participants will be held to gather qualitative data regarding the vegetable initiative.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
29
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21202
- Johns Hopkins Community Physicians at East Baltimore Medical Center
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Patients with uncontrolled diabetes mellitus (defined as a glycosylated hemoglobin >8%)
- 18 years age of and over
- Living within the geographical region of East Baltimore Medical Campus
Exclusion Criteria:
- Current participation in Five Plus Nuts and Beans Study or other program that provides diet-based food
- Non-English speaking
- On hospice or palliative care
- Acute or chronic psychosis
- Active substance or alcohol use disorder
- Another active medical disorder that would preclude participation in weekly food pick-up or classes including: active treatment of cancer, steroid dependent asthma/chronic obstructive pulmonary disease/emphysema, steroid dependent colitis; chronic kidney disease with an estimated glomerular filtration rate less than 30mg/mmol, venous thromboembolic disease with current treatment with vitamin K antagonist, Celiac disease, cirrhosis or steroid dependent arthritis
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Healthy food and Education/Cooking Classes
At consent, participant will complete the baseline survey.
Baseline survey will collect information like vegetable consumption, healthy eating attitudes, and demographics.
Every week for 6 weeks, participants will pick-up a healthy food bag (e.g.
fresh vegetables) for a $3 co-pay and attend an hour-long education classes at East Baltimore Medical Center.
All participants will complete a survey at healthy food bag pick-up or an education class.
Surveys at bag pick-up will ascertain outcomes like vegetable consumption.
Surveys at education classes will ascertain outcomes like healthy eating attitudes.
At 6 weeks, all participants will complete a follow-up survey equivalent to the baseline survey.
The follow-up survey will be completed again at 10 weeks, 18 weeks, and 30 weeks.
Participants will also be weighed at each bag pick-up (participants may decline) and relevant health information like blood pressure will be obtained from the EMR from an associated office visit.
|
The intervention includes providing weekly seasonal produce and healthy foods to participants in addition to an education/cooking class that will be tailored to Diabetes Mellitus, Type II.
|
|
Ingen indgriben: Control Group
At consent, participant will complete the baseline survey.
Baseline survey will collect information like vegetable consumption, cooking habits, food security, healthy eating attitudes, and demographics.
As a control group, participants will not partake in the healthy food bag pick-ups or cooking classes therefore they will not fill out those associated surveys.
After the 6 weeks of the intervention, control participants will be given the follow-up survey equivalent to the baseline survey.
The follow-up survey will be completed again after 10 weeks, 18 weeks, and 30 weeks.
Participants will also be weighed at each bag pick-up (participants may decline) and relevant health information like blood pressure will be obtained from the EMR from an associated office visit.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in amount of vegetables eaten
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Self-reported number of vegetables eaten per day (e.g. 2 vegetables/day) will be obtained by the survey.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
|
Change in weight (kg)
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Recorded from Electronic Medical Record (EMR) or weighed at weekly bag pick-up.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
|
Change in Body mass index (kg/m^2)
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Recorded from EMR or calculated with height of record.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Glycosylated Hemoglobin level (percent of mmol/mol)
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Recorded from EMR.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
|
Change in Blood pressure (mmHg)
Tidsramme: Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Recorded from EMR.
|
Baseline, at 6 weeks, 10 weeks, 18 weeks and 30 weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Donald RB Miles, MD, Johns Hopkins Community Physicians
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
18. juni 2019
Primær færdiggørelse (Faktiske)
26. september 2019
Studieafslutning (Faktiske)
26. september 2019
Datoer for studieregistrering
Først indsendt
18. juni 2019
Først indsendt, der opfyldte QC-kriterier
18. juni 2019
Først opslået (Faktiske)
19. juni 2019
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
12. november 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
8. november 2019
Sidst verificeret
1. november 2019
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- IRB00164545
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Ingen
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Diabetes mellitus
-
State University of New York at BuffaloMedical University of South CarolinaAfsluttetDiabetes mellitus | Type 2 diabetes mellitus | Voksen-debuterende diabetes mellitus | Ikke-insulinafhængig diabetes mellitus | Ikke-insulinafhængig diabetes mellitus, type IIForenede Stater
-
Meir Medical CenterAfsluttetDiabetes mellitus type 2 | Diabetes mellitus, ikke-insulinafhængig | Diabetes mellitus, om oral hypoglykæmisk behandling | Voksen type diabetes mellitusIsrael
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.AfsluttetDiabetes mellitus, type 1 | Type 1 diabetes | Diabetes type 1 | Type 1 diabetes mellitus | Autoimmun diabetes | Diabetes mellitus, insulinafhængig | Juvenil-Debut Diabetes | Diabetes, autoimmun | Insulinafhængig diabetes mellitus 1 | Diabetes mellitus, insulinafhængig, 1 | Diabetes mellitus, skør | Diabetes Mellitus... og andre forholdForenede Stater
-
SanofiAfsluttetType 1-diabetes mellitus-type 2-diabetes mellitusUngarn, Den Russiske Føderation, Tyskland, Polen, Japan, Forenede Stater, Finland
-
Medtronic MiniMed, Inc.RekrutteringType 2 diabetes mellitus | Type 1 diabetes mellitusForenede Stater, Australien, New Zealand
-
Peking Union Medical College HospitalUkendtType 2 diabetes mellitus | Type 1 diabetes mellitus | Svangerskabsdiabetes mellitus | Pancreatogen diabetes mellitus | Prægestationsdiabetes mellitus | Diabetespatienter i perioperativ periodeKina
-
Insulet CorporationRekrutteringType 2 diabetes mellitus | Type 1 diabetes mellitusForenede Stater
-
State University of New York at BuffaloMedical University of South Carolina; National Institute of Diabetes and...AfsluttetDiabetes mellitus, type 2 | Diabetes mellitus, type II | Diabetes mellitus, voksendebut | Diabetes mellitus, ikke-insulinafhængig | Diabetes mellitus, ikke-insulinafhængigForenede Stater
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)AfsluttetDiabetes mellitus, type 2 | Diabetes mellitus, type II | Diabetes mellitus, voksendebut | Diabetes mellitus, ikke-insulinafhængig | Diabetes mellitus, ikke-insulinafhængigForenede Stater
-
Guang NingRekrutteringType 2 diabetes mellitus | Type 1 diabetes mellitus | Monogenetisk diabetes | Pancreatogen diabetes | Lægemiddel-induceret diabetes mellitus | Andre former for diabetes mellitusKina